Author Archive: AZBio

SGB and Yulex Partner to Double Guayule Rubber Yield Through an Accelerated Breeding Platform

Posted on by

SAN DIEGO, CA and PHOENIX, AZ–(Marketwired – Nov 12, 2013) –  SGB Inc., an agricultural biotechnology company, and Yulex  Corporation, a biomaterial company, announced today a collaboration to establish  a genomics and molecular breeding platform focused on accelerating the crop  improvement of Guayule as a sustainable source of biorubber that can replace  traditional tropical or petroleum-based rubber for medical, consumer and  industrial markets.Continue reading→

W.L.Gore receives new FDA Approval and CE Mark on two innovative technologies

Posted on by

Its been a banner week for the medical division of W.L. Gore & Associates.  The Flagstaff-based medical device company announced FDA approval of its GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on November 6, 2013 followed by the announcement of receiving a CE mark for its the GORE EXCLUDER  Iliac Branch Endoprosthesis on November 7, 2013. Continue reading→

Mark C. Miller Joins Accelerate Diagnostics Board of Directors

Posted on by

TUCSON, Ariz., Nov. 6, 2013 — Accelerate Diagnostics, Inc. , an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Mark C. Miller has been appointed to its Board of Directors.

Mr. Miller currently serves as Executive Chairman and director of Stericycle  where he was Chief Executive Officer from 1992 to 2012 and Chairman of the Board of Directors from 2008 to 2012. During his 20 years as CEO, Mark grew Stericycle’s revenues from $1.6 million to $1.9 billion, and in 2009 was selected by Morningstar, Inc. as its “CEO of the Year.” Prior to joining Stericycle, Mr. Miller served as vice president for the Pacific, Asia and Africa in the international division of Abbott Laboratories, a diversified health care company, which he joined in 1976 and where he held a number of management and marketing positions. Mr. Miller formerly served as a director of Ventana Medical Systems, Inc., a developer and supplier of automated diagnostic systems. He received a B.S. degree in computer science from Purdue University, where he graduated Phi Beta Kappa.

“We are pleased to have Mark join our Board. His leadership, expertise and wisdom were crucial to the tremendous success of Stericycle. We are looking forward to him applying these skills at Accelerate Diagnostics,” commented John Patience, Accelerate Diagnostic’s Chairman.

ABOUT ACCELERATE DIAGNOSTICS

Accelerate Diagnostics, Inc is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections. We are focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel(TM) platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity.

In addition to the BACcel system development pipeline, Accelerate Diagnostics also owns and licenses its propriety OptiChem® surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.